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E D I T O R I A L
Elimination of the donor service area (DSA) from lung 
allocation: No turning back
Following the issuance of the Final Rule governing the Organ 
Procurement	and	Transplantation	Network	(OPTN)	in	1998,	the	then	
Chair of the OPTN Thoracic Transplantation Committee (hereafter 
referred	 to	 as	 the	 Committee)	 cited	 and	 supported	 the	 American	
Society of Transplant Surgeons testimony before Congress stating 
“giving priority to the sickest patients first over broad geographic 
areas	would	be	wasteful	and	dangerous,	resulting	in	fewer	patients	
transplanted,	 increased	 death	 rates,	 increased	 re‐transplantation	
due to poor organ function and increased overall cost of transplan‐
tation”.1	Despite	 early	 opposition,	 the	OPTN	Final	 Rule	went	 into	
effect in 2000 requiring that organs be distributed over as broad a 
geographic area as feasible in order of decreasing medical urgency. 
The Committee immediately focused on creating a lung alloca‐
tion	 score	 (LAS)	 to	prioritize	waitlisted	patients	based	on	 severity	
of	 illness	 and	 transplant	 benefit.	 LAS	 implementation	 in	 2005	 led	
to	 a	 reduction	 in	 waitlist	 mortality,	 change	 in	 transplant	 distribu‐
tion	diagnoses	 to	 recipients	more	 likely	 to	die	on	 the	waitlist,	 and	
improved	 posttransplant	 1‐year	 survival.2	 In	 November	 2017,	 the	
OPTN Executive Committee made an emergency policy change 
to align lung allocation with the geographic aspects of the OPTN 
Final	Rule.	This	 eliminated	 the	donation	 service	 area	 (DSA)	 as	 the	
first	 unit	 of	 distribution,	 replacing	 it	 by	 a	 circle	with	 a	 250	 nauti‐
cal	mile	(NM)	radius,	centered	on	the	donor	hospital.	The	OPTN	has	
been	closely	monitoring	and	reporting	on	these	changes,	intended	to	
allow broader distribution to the most medically urgent candidates 
based	on	the	LAS.
In this issue of American Journal of Transplantation,	 Puri	 and	
colleagues	offer	 important	 interpretations	of	 the	OPTN	6‐month	
monitoring report along with additional insights into the impact on 
costs and travel for their institutions.3 They conclude that while 
there	was	an	expected	 fall	 in	 the	use	of	 local	 (within	DSA)	 lungs	
(56%	decline),	 increased	 total	 ischemic	 time	 (5.33	 to	5.53	hours),	
and	increase	in	the	mean	LAS	at	transplant	(47.85	vs	49.96),	there	
was	no	decline	 in	waitlist	mortality,	no	change	 in	the	type	of	pa‐
tients	 receiving	 a	 lung	 transplant,	 an	 increase	 in	 the	 number	 of	
lungs	discarded,	and	a	 substantial	 increase	 in	median	 local	organ	
procurement	cost	 ($34	000	 to	$70	203)	when	compared	 to	data	
prior to policy change.3
The	data	referenced	by	Puri	et	al	has	been	updated	in	a	1‐year	
postpolicy monitoring report (https://optn.transplant.hrsa.gov/
media/2815/20190116_thoracic_committee_report_lung.pdf).4 
Under	 the	new	system,	 the	median	distance	 lungs	are	 traveling	
has increased from 114NM to 166NM with a mean ischemic time 
increase	of	≈13	minutes	(5.32	to	5.55	hours).	The	data	highlight	a	
statistically	significant	increase	in	the	mean	LAS	(47.25	vs	49.61,	
P < .0001) for transplant recipients. While Puri et al imply that 
this	change	might	not	be	clinically	meaningful,	an	acute	change	
in	the	LAS	of	patients	with	an	LAS	>	40	is	associated	with	a	sig‐
nificantly	greater	 risk	of	waitlist	death,	and	an	 increase	 in	 rela‐
tive	 transplant	 survival	 benefit	 is	 conferred	by	 a	 higher	 LAS	 at	
time of transplantation.5,6	Under	the	new	policy,	there	have	been	
59	 more	 transplants	 for	 candidates	 with	 an	 LAS	 70+,	 77	 with	
LAS	60‐70,	and	55	with	LAS	50‐60	compared	to	the	same	time	
period prepolicy. The OPTN report shows a statistically signif‐
icant	decrease	in	the	waitlist	mortality	rate	for	60‐70	LAS	candi‐
dates	 (relative	 risk	=	0.37,	95%	confidence	 interval:	0.16,	0.85).	
Therefore,	1‐year	monitoring	data	show	that	under	the	new	pol‐
icy,	lungs	are	traveling	further	with	a	subsequent	increase	in	high	
LAS	 transplants	 and	 a	 decrease	 in	 waitlist	 mortality	 for	 some	
high	LAS	groups.
When	examining	lung	utilization,	the	utilization	rate	(percent‐
age of donors with at least 1 lung transplanted) may be a more ap‐
propriate metric than discard rate (percentage of lungs discarded 
out of those recovered for transplant) since lungs are rarely re‐
covered	and	not	 transplanted.	Since	the	national	utilization	rate	
did	not	change	(22.59%	vs	22.49%),	the	Committee	discussed	the	
geographic	 variation	 in	 utilization	 rate	 that	was	 identified	 prior	
to the alteration in allocation. The most recent monitoring report 
shows	 that	 the	utilization	 rate	by	OPTN	region	 ranges	between	
14%	and	28%.
With	lungs	often	traveling	further,	the	total	cost	for	organ	allo‐
cation	inevitably	will	increase,	primarily	due	to	transportation	fees.	
The authors suggest a potential doubling of the median cost of organ 
procurement	($34	000	to	$70	203).	Such	increases	have	been	cited	
in	models	of	broader	geographic	sharing	for	other	organs,	but	may	
be	 offset	 by	 reduced	 costs	 for	 pretransplant	 care,	 transplant	 epi‐
sode,	and/or	posttransplant	care.7,8
Potential solutions to the current policy suggested by the authors 
include	 the	 use	 of	 regional	 procurement	 teams,	 offering	 broader	
sharing	only	to	sicker	individuals	based	on	LAS	(LAS	≥	50)	and/or	to	
patients based on multidimensional parameters that are traditional 
barriers	to	transplantation	(eg,	short	stature,	allosensitization).
The	Committee	adopted	the	November	2017	change	with	the	un‐
derstanding	that	an	optimized	lung	allocation	model	would	be	the	next	
Committee	project.	In	2018,	the	OPTN	formed	an	Ad	Hoc	Geography	
Committee to define guiding principles for the use of geographic 
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constraints in allocation. For eventual application in all organ allocation 
policies,	 the	Geography	Committee	suggested	a	continuous	distribu‐
tion	framework,	which	the	OPTN	Board	approved	in	December	2018.	
In	February	2019,	the	Thoracic	Committee	began	the	task	of	refining	
the current system to align with such a framework.9 Some of the sug‐
gestions	made	by	Puri	and	colleagues	to	optimize	lung	allocation	can	be	
incorporated into this model.
The intent of the OPTN Final Rule was to ensure equity of US 
organ	 allocation	 and	 thankfully,	 earlier	 concerns1 did not portend 
the	future.	Having	successfully	 tackled	the	provision	requiring	the	
allocation	of	lungs	in	order	of	decreasing	medical	urgency,	we	as	a	
community are now obligated to remove the impediment of geo‐
graphic boundaries that were not established for the purpose of ef‐
fective or equitable organ distribution.
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